AZD1305
AZD1305 is a pharmaceutical drug with 13 clinical trials. Historical success rate of 92.3%.
Success Metrics
Based on 12 completed trials
Phase Distribution
Phase Distribution
9
Early Stage
4
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
92.3%
12 of 13 finished
7.7%
1 ended early
0
trials recruiting
13
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Intravenous Cardioversion of Atrial Fibrillation (AF) With AZD1305
Explorative Study of AZD1305 in Atrial Fibrillation Patients
Cardiac Electrophysiological Study
Investigate the Effect of AZD1305 on Patients With Left Ventricular Dysfunction
AZD1305 Single and Multiple Ascending Dose Study in Healthy Japanese and Caucasian Subjects
Clinical Trials (13)
Intravenous Cardioversion of Atrial Fibrillation (AF) With AZD1305
Explorative Study of AZD1305 in Atrial Fibrillation Patients
Cardiac Electrophysiological Study
Investigate the Effect of AZD1305 on Patients With Left Ventricular Dysfunction
AZD1305 Single and Multiple Ascending Dose Study in Healthy Japanese and Caucasian Subjects
Study of an Extended Release (ER) Tablet, Single and Repeated Dosing
An Interaction Study With Digoxin and AZD1305
Evaluate Different Extended-release (ER) Tablets/Capsules of AZD1305
An Interaction Study of Ketoconazole/Verapamil Versus AZD1305
To Study the Absorption, Distribution, Metabolism and Excretion of AZD1305
Single Ascending Dose Study (SAD) iv Formulation
Study to Assess Drug Concentrations in Plasma of Different Extended-release Formulations of AZD1305
To Study Safety, Tolerability and Pharmacokinetics of AZD1305 in Healthy Male Japanese Subjects
All 13 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 13